Effects of NADPH oxidase inhibitor on diabetic nephropathy in OLETF rats: The role of reducing oxidative stress in its protective property

2009 ◽  
Vol 83 (2) ◽  
pp. 176-182 ◽  
Author(s):  
Soo Min Nam ◽  
Mi Young Lee ◽  
Jang Hyun Koh ◽  
Jun Ho Park ◽  
Jang Yel Shin ◽  
...  
2008 ◽  
Vol 228 (3) ◽  
pp. 277-285 ◽  
Author(s):  
Chiara Riganti ◽  
Costanzo Costamagna ◽  
Sophie Doublier ◽  
Erica Miraglia ◽  
Manuela Polimeni ◽  
...  

2013 ◽  
Vol 63 (6) ◽  
pp. 583-593 ◽  
Author(s):  
Ana Paula Oliveira Ferreira ◽  
Fernanda Silva Rodrigues ◽  
Iuri Domingues Della-Pace ◽  
Bibiana Castagna Mota ◽  
Sara Marchesan Oliveira ◽  
...  

2006 ◽  
Vol 212 (3) ◽  
pp. 179-187 ◽  
Author(s):  
C RIGANTI ◽  
C COSTAMAGNA ◽  
A BOSIA ◽  
D GHIGO

2006 ◽  
Vol 290 (6) ◽  
pp. L1069-L1077 ◽  
Author(s):  
Albert C. Grobe ◽  
Sandra M. Wells ◽  
Eileen Benavidez ◽  
Peter Oishi ◽  
Anthony Azakie ◽  
...  

Although oxidative stress is known to contribute to endothelial dysfunction-associated systemic vascular disorders, its role in pulmonary vascular disorders is less clear. Our previous studies, using isolated pulmonary arteries taken from lambs with surgically created heart defect and increased pulmonary blood flow (Shunt), have suggested a role for reactive oxygen species (ROS) in the endothelial dysfunction of pulmonary hypertension, but in vivo data are lacking. Thus the initial objective of this study was to determine whether Shunt lambs had elevated levels of ROS generation and whether this was associated with alterations in antioxidant capacity. Our results indicate that superoxide, but not hydrogen peroxide, levels were significantly elevated in Shunt lambs. In addition, we found that the increase in superoxide generation was not associated with alterations in antioxidant enzyme expression or activity. These data suggested that there is an increase in superoxide generation rather than a decrease in scavenging capacity in the lung. Thus we next examined the expression of various subunits of the NADPH oxidase complex as a potential source of the superoxide production. Results indicated that the expression of Rac1 and p47phox is increased in Shunt lambs. We also found that the NADPH oxidase inhibitor diphenyliodonium (DPI) significantly reduced dihydroethidium (DHE) oxidation in lung sections prepared from Shunt but not Control lambs. As DPI can also inhibit endothelial nitric oxide synthase (eNOS) superoxide generation, we repeated this experiment using a more specific NADPH oxidase inhibitor (apocynin) and an inhibitor of NOS (3-ethylisothiourea). Our results indicated that both inhibitors significantly reduced DHE oxidation in lung sections prepared from Shunt but not Control lambs. To further investigate the mechanism by which eNOS becomes uncoupled in Shunt lambs, we evaluated the levels of dihydrobiopterin (BH2) and tetrahydrobiopterin (BH4) in lung tissues of Shunt and Control lambs. Our data indicated that although BH4 levels were unchanged, BH2 levels were significantly increased. Finally, we demonstrated that the addition of BH2 produced an increase in superoxide generation from purified, recombinant eNOS. In conclusion our data demonstrate that the development of pulmonary hypertension in Shunt lambs is associated with increases in oxidative stress that are not explained by decreases in antioxidant expression or activity. Rather, the observed increase in oxidative stress is due, at least in part, to increased expression and activity of the NADPH oxidase complex and uncoupled eNOS due to elevated levels of BH2.


2021 ◽  
Vol 36 (Supplement_1) ◽  
Author(s):  
Yu Ah Hong ◽  
Keum-Jin Yang ◽  
Wonjung Choi ◽  
Yoon-Kyung Chang ◽  
Cheol Whee Park ◽  
...  

Abstract Background and Aims Xanthine oxidase (XO) is one of major source of reactive oxygen species, and a XO inhibitor, febuxostat has been reported to the protection of kidney diseases. We investigated whether febuxostat exerts renoprotective effects against diabetic nephropathy (DN). Method Eight-week Male C57BL/6 mice were divided into four groups: Control group (Cont), Febuxostat control group (FEB), streptozotocin treated group (STZ) and a febuxostat and STZ-treated diabetes group (STZ+FEB). STZ was used to induce diabetes (50 mg/kg/day, 5 days), and 5 mg/kg of febuxostat was treated to experimental mice for 8 weeks. Results STZ-treated diabetic mice were significantly decreased in serum and kidney XO levels, serum cystatin C and albuminuria by febuxostat treatment. Febuxostat treatment decreased renal hypertrophy and mesangial matrix expansion in STZ-treated diabetic mice. Febuxostat treatment suppressed the expression of vascular endothelial growth factor (VEGF)1 and 3, NADPH oxidase (NOX)1, 2, and 4, and the levels of their catalytic subunit mRNA in in STZ-treated diabetic mice. Febuxostat treatment was accompanied by the downregulation of Akt phosphorylation, followed by the suppression of transcription factor forkhead box O3a phosphorylation and the enhancement of endothelial nitric oxide synthase. Finally, febuxostat improved oxidative stress and resulted in decreased 8-hydroxy-2'-deoxyguanosine and kidney malondialdehyde levels, and increased superoxide dismutase activity in STZ-treated diabetic mice. Conclusions Febuxostat attenuated DN by modulating oxidative stress and endothelial function through VEGF–NADPH oxidase signaling pathway.


Sign in / Sign up

Export Citation Format

Share Document